Advertisement
UK markets closed

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • CRUDE OIL

    82.90
    +1.00 (+1.22%)
     

  • GOLD FUTURES

    2,339.30
    -7.10 (-0.30%)
     

  • DOW

    38,485.00
    +245.02 (+0.64%)
     

  • Bitcoin GBP

    53,530.44
    +364.58 (+0.69%)
     

  • CMC Crypto 200

    1,436.30
    +21.54 (+1.52%)
     

  • NASDAQ Composite

    15,684.00
    +232.69 (+1.51%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

3 Growth Stocks That Are Too Cheap to Ignore

Rachel Warren, The Motley Fool
·5-min read
3 Growth Stocks That Are Too Cheap to Ignore

The stock market hates uncertainty, and the global factors driving the market in 2022 have understandably left many investors feeling frustrated. While no one can predict when this volatile period will wrap up, the history of the stock market has shown that patient investors who maintain stakes in great businesses can sustain and compound rewarding returns with time. Currently, the company relies on its portfolio of cystic fibrosis (CF) medicines to drive revenue and profits, and it continues to deliver on both fronts year after year.

Continue reading